I have to say that I share your sentiment, even though it appears as though not that many do.
My only hope is that the reason for offering so much is that it incentivises him to take a half decent offer from big pharma. The institutional investors know that this is how you get, the narcissistic, CEOs to make decisions and not have them constantly holding out for the earth shattering deal that will probably never come.
I'm starting to think that they have already had some offers but the CEO is holding out for close to $US2B.
